Shopping Cart
- Remove All
Your shopping cart is currently empty
SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM), blocking activation of the receptor by the synthetic agonist GSK 4112

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $42 | In Stock | |
| 5 mg | $98 | In Stock | |
| 10 mg | $163 | In Stock | |
| 25 mg | $318 | In Stock | |
| 50 mg | $460 | In Stock | |
| 100 mg | $676 | In Stock | |
| 200 mg | $962 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $108 | In Stock |
| Description | SR8278 is an REV-ERBα antagonist(EC50 = 0.47 μM), blocking activation of the receptor by the synthetic agonist GSK 4112 |
| In vitro | SR8278 stimulates the expression of two REV-ERBα target genes involved in the regulation of glucose production, glucose 6-phosphatase and phosphoenolpyruvate carboxykinase, in liver cells[1] |
| Molecular Weight | 361.48 |
| Formula | C18H19NO3S2 |
| Cas No. | 1254944-66-5 |
| Smiles | CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(SC)s1 |
| Relative Density. | 1.32 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (138.32 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.